# LGM Pharma Solutions, LLC - Inspection Records Source: https://www.keypedia.com/companies/lgm-pharma-solutions-llc/5ee22c42-8e6e-4af9-a2b7-832e0d586f19 > Inspection records and compliance data for LGM Pharma Solutions, LLC in Irvine, California. Access full analysis and detailed observations. --- ## Details - Name: LGM Pharma Solutions, LLC - FEI Number: 3017140477 - City: Irvine - State: California - Country Name: United States - Address Line 1: 17802 Gillette Ave - Zip Code: 92614 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [483 - LGM Pharma Solutions, LLC - 2026-05-18](https://www.keypedia.com/records/483/lgm-pharma-solutions-llc/3de1b8bb-d84a-44df-a320-9014410545f1) — source: FDA, date: May 18, 2026 - [FDA Inspection 1232056 - LGM Pharma Solutions, LLC - 2025-01-24](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/618e10e1-dad1-4647-a441-9ddec9afd566) — source: FDA, date: January 24, 2025 - [FDA Inspection 1232056 - LGM Pharma Solutions, LLC - 2025-01-24](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/f80c6bd3-5928-4b4c-ac57-81589a52ba2a) — classification: No Action Indicated (NAI), source: FDA, date: January 24, 2025 - [483 - LGM Pharma Solutions, LLC - 2024-03-01](https://www.keypedia.com/records/483/lgm-pharma-solutions-llc/0f59dd4a-490d-41b1-a687-2ef6fdeacee1) — source: FDA, date: March 1, 2024 - [483 - LGM Pharma Solutions, LLC - 2024-03-01](https://www.keypedia.com/records/483/lgm-pharma-solutions-llc/fbc5e811-568b-41cb-9541-fed0314350c7) — source: FDA, date: March 1, 2024 - [FDA Inspection 1230374 - LGM Pharma Solutions, LLC - 2024-03-01](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1d4efc76-d6cb-4820-a2a8-d28f1e3bc96a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 1, 2024 - [FDA Inspection 1120565 - LGM Pharma Solutions, LLC - 2020-01-31](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/959c277c-a14b-4450-8529-7d62cbe3505b) — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2020 - [FDA Inspection 1062404 - LGM Pharma Solutions, LLC - 2018-08-17](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1db1a1e8-3ccd-408e-9152-9b6bc20d6163) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2018 - [FDA Inspection 1006282 - LGM Pharma Solutions, LLC - 2017-02-13](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/86257d39-a391-41fc-886e-2c7722430735) — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2017 - [FDA Inspection 1007414 - LGM Pharma Solutions, LLC - 2016-12-13](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/aa4cce69-c65b-475b-9890-8d5d670382ae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2016 - [FDA Inspection 887244 - LGM Pharma Solutions, LLC - 2014-07-11](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/7a9a78d4-7047-4d1e-baf8-b3953e8d5fae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 11, 2014 - [FDA Inspection 776102 - LGM Pharma Solutions, LLC - 2012-04-09](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/691f6786-85aa-4e65-92d0-f64f82a18450) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 9, 2012 - [FDA Inspection 723041 - LGM Pharma Solutions, LLC - 2011-05-05](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/648afa23-c490-465f-b465-956253c9d089) — classification: No Action Indicated (NAI), source: FDA, date: May 5, 2011 ## Related Companies - [Sun Pharmaceutical Industries, Inc.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-inc/1a56d6cb-288c-42d5-9558-e4301ffebc65) - [Finish Line Horse Products, Inc.](https://www.keypedia.com/companies/finish-line-horse-products-inc/205e6869-8995-4e35-9af4-e022b2dedb77) - [Haupt Pharma Wuelfing GmbH](https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0) - [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b) - [Fareva Richmond, Inc.](https://www.keypedia.com/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb) - [Wasserburger Arzneimittelwerk GmbH](https://www.keypedia.com/companies/wasserburger-arzneimittelwerk-gmbh/01756512-83f0-4432-8ab4-ea57cec1dfcc) - [Nice-Pak Products, Inc.](https://www.keypedia.com/companies/nice-pak-products-inc/675a57a1-c8c6-40db-8b8f-081c66bf4193) - [Radienz Living LLC](https://www.keypedia.com/companies/radienz-living-llc/eb0c62f0-67bb-4fab-a929-74e29b70427e) - [Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/60558281-5fe9-47ef-a772-a976c821d6b2) - [LEO Pharma Ireland](https://www.keypedia.com/companies/leo-pharma-ireland/59203974-017b-455b-b585-13cd35d25ed9) ## Related Officers - [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e) - [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84) - [Professor of Medicine](https://www.keypedia.com/people/lawrence-r-deyton/92881ee2-c62d-4faf-b619-4900022cc779) - [Program Division Director](https://www.keypedia.com/people/randy-f-pack/c4e89614-5aa6-4d3f-90dc-68482b499967) - [Thuy Tram L. Nguyen](https://www.keypedia.com/people/thuy-tram-l-nguyen/b58f2445-728e-4f79-b7eb-4dfb7e982e25) - [Journey V Cordero](https://www.keypedia.com/people/journey-v-cordero/caf484dc-3e04-42a0-a063-9b5fb184f47d)